Research Article
Sarcopenic Obesity and Cognitive Functioning: The Mediating Roles of Insulin Resistance and Inflammation?
Table 4
Coefficients predicting cognitive functioning for subjects aged 70+.
| | Model 1 | Model 2 | Model 3 |
| Sarcopenic obese | −7.08 (1.28)*** | −5.66 (1.28)*** | −7.19 (1.28)*** | Solely sarcopenic | −4.19 (0.82)*** | −4.39 (0.82)*** | −4.20 (0.82)*** | Solely obese | −1.43 (0.68)* | 0.51 (0.73) | −1.63 (0.69)* | Black | −14.33 (1.19)*** | −14.23 (1.18)*** | −14.40 (1.19)*** | Hispanic | −9.19 (1.01)*** | −9.56 (1.01)*** | −9.33 (1.01)*** | Other | −7.35 (2.03)*** | −7.40 (2.01)*** | −7.47 (2.03)*** | Age (75–79) | −3.10 (0.59)*** | −2.91 (0.59)*** | −3.04 (0.59)*** | Age (80–84) | −8.42 (0.68)*** | −8.07 (0.67)*** | −8.35 (0.68)*** | Age (85+) | −12.02 (0.91)*** | −12.49 (0.91)*** | −12.03 (0.91)*** | Education | 2.25 (0.08)*** | 2.21 (0.08)*** | 2.24 (0.08)*** | Female | 3.68 (0.75)*** | 3.04 (0.75)*** | 3.80 (0.75)*** | Height | −0.11 (0.04)** | −0.13 (0.04)** | −0.10 (0.04)* | History of CVD | −2.63 (0.61)*** | −2.42 (0.61)*** | −2.64 (0.61)*** | Low physical activity | −3.11 (0.57)*** | −2.83 (0.56)*** | −3.14 (0.57)*** | Hypoalbuminemia | −4.12 (1.44)** | −4.35 (1.43)** | −4.70 (1.45)** | Hyperhomocysteinemia | −0.11 (0.89) | −0.27 (0.89) | −0.26 (0.90) | IRHOMA | | −3.02 (0.45)*** | | CRP | | | 0.47 (0.24) | squared | .387 | .397 | 0.388 |
|
|
.
|